Covered recipient · General Payments record
BRIAN KEITH HARRIS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,271.74
- Reported across 82 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $275.24 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $64.00 | 3 |
| Amgen Inc. | $60.08 | 4 |
| iRhythm Technologies, Inc. | $31.07 | 1 |
| Medtronic, Inc. | $20.35 | 1 |
| Novo Nordisk AS | $18.74 | 1 |
| Astellas Pharma US Inc | $18.49 | 1 |
| Exact Sciences Corporation | $17.09 | 1 |
| GlaxoSmithKline, LLC. | $16.60 | 1 |
| Sonex Health, Inc. | $15.48 | 1 |
| DEXCOM, INC. | $13.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.91 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103882782 | CMS |
| ABBVIE INC. | $24.44 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103882784 | CMS |
| ABBVIE INC. | $20.65 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103882786 | CMS |
| Amgen Inc. | $14.04 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117272363 | CMS |
| Amgen Inc. | $15.06 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117272365 | CMS |
| Amgen Inc. | $16.19 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117272367 | CMS |
| Amgen Inc. | $14.79 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117272369 | CMS |
| Astellas Pharma US Inc | $18.49 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139325054 | CMS |
| Dexcom, Inc. | $13.34 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153288020 | CMS |
| Exact Sciences Corporation | $17.09 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114693896 | CMS |
| GlaxoSmithKline, LLC. | $16.60 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115800322 | CMS |
| iRhythm Technologies, Inc. | $31.07 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154055862 | CMS |
| Medtronic, Inc. | $20.35 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119394982 | CMS |
| Novo Nordisk Inc | $18.74 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096568058 | CMS |
| Sonex Health, Inc. | $15.48 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134569018 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.